Observational studyNeurology2026

Risk of New Indications for Anticoagulants and Thrombolytics in People With Cognitive Impairment: Implications for Anti-Amyloid Therapy.

Anna L Parks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.